Deltagen Inc. (DGEN) Research

Deltagen Inc. furnishes specialized tools and services crucial for drug discovery, serving both the biopharmaceutical sector and academic research institutions throughout the United States. The company delivers a comprehensive portfolio of programs designed to streamline and accelerate the drug development process. These offerings include access to vital biological models and identified therapeutic targets, specifically within the small-molecule and secreted protein categories. Additionally, Deltagen supplies critical data for target validation, particularly focusing on immunological and metabolic diseases. The firm was established in 1997 and its main operations are based in San Mateo, California.

Market snapshot

Symbol
DGEN
Price
$0.00
Day change
0.00%
Market cap
$3.9K
52-week range
0.0001-0.0001
Sector
Healthcare
Industry
Medical - Instruments & Supplies

Peer companies

  • Ventura Cannabis & Wellness Corporation (CVHIF)
  • Cyclo3pss Corporation (CYPS)
  • Nemaura Medical Inc. (NMRD)
  • Net Medical Xpress Solutions, Inc. (NMXS)
  • Quick-Med Technologies, Inc. (QMDT)
  • Remedent, Inc. (REMI)
  • THC Therapeutics, Inc. (THCT)
  • Tengion, Inc. (TNGNQ)

Open Deltagen Inc. (DGEN) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.